CYP450- and COMT-derived estradiol metabolites inhibit activity of human coronary artery SMCs

Hypertension

Volumn 41, Issue 3 II, 2003, Pages 807-813

  Dubey, Raghvendra K ^a,b   Gillespie, Delbert G ^b   Zacharia, Lefteris C ^b   Barchiesi, Federica ^a   Imthurn, Bruno ^a,b   Jackson, Edwin K ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Cardiovascular diseases; Coronary artery disease; Estrogen; Hormones; Menopause; Metabolism; Remodeling

Indexed keywords

1 AMINOBENZOTRIAZOLE; 3 METHYLCHOLANTHRENE; 3,5 DINITROPYROCATECHOL; BETA NAPHTHOFLAVONE; CATECHOL METHYLTRANSFERASE; CATECHOL METHYLTRANSFERASE INHIBITOR; CYTOCHROME 1A2 INHIBITOR; CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; CYTOCHROME P450 1B1 INHIBITOR; CYTOCHROME P450 3A4 INHIBITOR; CYTOCHROME P450 INHIBITOR; ESTRADIOL; ESTRADIOL 3 METHYL ETHER; ESTRIOL; FULVESTRANT; FURAFYLLINE; KETOCONAZOLE; PHENOBARBITAL; QUERCETIN; UNCLASSIFIED DRUG;

CELL ACTIVITY; CELL COUNT; CELL MIGRATION; COLLAGEN SYNTHESIS; CONFERENCE PAPER; CONTROLLED STUDY; CORONARY ARTERY; DNA SYNTHESIS; DRUG EFFECT; DRUG INHIBITION; DRUG POTENTIATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ARYL HYDROCARBON HYDROXYLASES; CATECHOL O-METHYLTRANSFERASE; CELL DIVISION; CELL MOVEMENT; CELLS, CULTURED; COLLAGEN; CORONARY VESSELS; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INHIBITORS; ESTRADIOL; FEMALE; HUMANS; MUSCLE, SMOOTH, VASCULAR;

EID: 0037342726     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000048862.28501.72     Document Type: Conference Paper

References (17)

1. Dubey RK, Jackson EK. Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms. Am J Physiol. 2001;280:F365-F388.
2. Dubey RK, Gillespie DG, Zacharia LC, Imthurn B, Jackson EK, Keller PJ. Clinically used estrogens differentially inhibit human aortic smooth muscle cell growth and MAP kinase activity. Arterioscler Thromb Vas Biol. 2000;20:964-972.
3. Barchiesi F, Jackson EK, Gillespie DG, Zacharia LC, Fingerle J, Dubey RK. Methoxyestradiols mediate estradiol-induced antimitogenesis in human aortic SMCs. Hypertension. 2002;39:874-879.
4. Iafrati MD, Karas RH, Aronovitz M, Kim S, Sullivan TR, Lubahn DB, O'Donnell TF, Korach KS, Mendelsohn ME. Estrogen inhibits the vascular injury response in estrogen receptor a deficient mice. Nature Med. 1997;3:545-548.
5. Karas RH, Hodgin JB, Kwoun M, Krege JH, Aronovitz M, Mackey W, Gustafsson JA, Korach KS, Smithies O, Mendelsohn ME. Estrogen inhibits the vascular injury response in estrogen receptor β-deficient female mice. Proc Natl Acad Sci U S A. 1999;96:15133-15136.
6. Karas RH, Schulten H, Pare G, Aronovitz MJ, Ohlsson C, Gustafsson JA, Mendelsohn ME. Effects of estrogen on the vascular injury response in estrogen receptor α,β (double) knockout mice. Circ Res. 2001;89:534-539.
7. Zhu BT, Conney AH. Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis (Lond). 1998;19:1-27.
8. Martucci CP, Fishmann J. P450 enzyme of estrogen metabolism. Pharmacol Ther. 1993;57:237-257.
9. Mànnisto PT, Kaakkola S. Catechol-o-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev. 1999;51:593-628.
10. Zacharia LC, Jackson EK, Gillespie DG, Dubey RK. Increased 2-methoxyestradiol production in human coronary versus aortic vascular cells. Hypertension. 2001;37:658-662.
11. Shimada T, Yamazaki H, Foroozesh M, Hopkins NE, Alworth WL, Guengerich FP. Selectivity of polycyclic inhibitors for human cytochrome P450s 1A1, 1A2 and 1B1. Chem Res Toxicol. 1998;11:1048-1056.
12. Dubey RK, Gillespie DG, Zacharia LC, Rosselli M, Korzekwa KR, Fingerle J, Jackson EK. Methoxyestradiols mediate the antimitogenic effects of estradiol on vascular smooth muscle cells via estrogen receptor-independent mechanisms. Biochem Biophys Res Commun. 2000;278:27-33.
13. Ball P, Knuppen R. Formation, metabolism, and physiological importance of catecholestrogens. Am J Obstet Gynecol. 1990;163:2163-2170.
14. Aldercreutz H, Gorbach SL, Goldin BR, Woods MN, Dwyer JT, Hamalainen E. Estrogen metabolism and excretion in Oriental and Caucasian Women. J Natl Cancer Inst. 1994;86:1076-1082.
15. Lee AJ, Mills LH, Kosh JW, Conney AH, Zhu BT. NADPH-dependent metabolism of estrone by human liver microsomes. J Pharmacol Exp Therap. 2002;300:838-849.
16. Zacharia LC, Jackson EK, Gillespie DG, Dubey RK. Catecholamines abrogate antimitogenic effects of 2-hydroxyestradiol on human aortic vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2001;21:1745-1750.
17. Dubey RK, Jackson EK. Cardiovascular protective effects of 17β-estradiol metabolites. J Appl Physiol. 2001;91:1868-1883.